Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma

BACKGROUND: Osteosarcoma (OSA) is a highly metastatic pediatric bone tumor. Adjuvant chemotherapy and surgical resection represent standard treatments; however, the prognosis is still poor. Effective strategies are urgently needed. Chondroitin sulfate proteoglycan (CSPG)4 is a transmembrane proteogl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Riccardo, Federica, Tarone, Lidia, Iussich, Selina, Giacobino, Davide, Arigoni, Maddalena, Sammartano, Federica, Morello, Emanuela, Martano, Marina, Gattino, Francesca, Maria, Raffaella De, Ferrone, Soldano, Buracco, Paolo, Cavallo, Federica
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6557023/
https://ncbi.nlm.nih.gov/pubmed/31217827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919855491
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars